LOW-DOSE ARA-C AS MAINTENANCE TREATMENT IN AML

被引:0
|
作者
CATALANO, L
FONTANA, R
SELLERI, C
DEROSA, G
ROTOLI, B
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:412 / 413
页数:2
相关论文
共 50 条
  • [41] LOW-DOSE ARA-C ADMINISTERED BY CONTINUOUS SUBCUTANEOUS INFUSION - A PHARMACOLOGICAL EVALUATION
    SPRIGGS, DR
    SOKAL, JE
    GRIFFIN, J
    KUFE, DW
    CANCER DRUG DELIVERY, 1986, 3 (03): : 211 - 216
  • [42] LOW-DOSE ARA-C THERAPY FOR ACUTE MYELOGENOUS LEUKEMIA IN ELDERLY PATIENTS
    POWELL, BL
    CAPIZZI, RL
    MUSS, HB
    BEARDEN, JD
    LYERLY, ES
    ROSENBAUM, DL
    MORGAN, TM
    RICHARDS, F
    JACKSON, DV
    WHITE, DR
    NELSON, EC
    BUTLER, WM
    ZEKAN, PJ
    CRUZ, JM
    COOPER, MR
    BUSS, DH
    SPURR, CL
    LEUKEMIA, 1989, 3 (01) : 23 - 28
  • [43] LOW-DOSE ARA-C THERAPY IN MYELODYSPLASTIC SYNDROMES AND ACUTE-LEUKEMIA
    GAYNOR, ER
    WINTER, JN
    VARIAKOJIS, D
    LARSON, RA
    CLINICAL RESEARCH, 1983, 31 (04): : A726 - A726
  • [44] LOW-DOSE ARA-C FAILS TO ENHANCE DIFFERENTIATION OF LEUKEMIC-CELLS
    PERRI, RT
    WEISDORF, DJ
    OKEN, MM
    BRITISH JOURNAL OF HAEMATOLOGY, 1985, 59 (04) : 697 - 701
  • [45] A Randomised Comparison of Clofarabine Versus Low Dose Ara-C As First Line Treatment for Older Patients with AML
    Burnett, Alan K.
    Russell, Nigel H.
    McMullin, Mary Frances
    Kell, Jonathan
    Ali, Sahra
    Moreton, Paul
    Wei, Andrew H.
    Kjeldsen, Lars
    Hills, Robert K.
    BLOOD, 2012, 120 (21)
  • [46] THE EFFECT OF LOW-DOSE ARA-C IN ACUTE NONLYMPHOBLASTIC LEUKEMIAS AND ATYPICAL LEUKEMIA
    ISHIKURA, H
    SAWADA, H
    OKAZAKI, T
    MOCHIZUKI, T
    IZUMI, Y
    YAMAGISHI, M
    UCHINO, H
    BRITISH JOURNAL OF HAEMATOLOGY, 1984, 58 (01) : 9 - 18
  • [47] SUCCESSFUL TREATMENT WITH LOW-DOSE ARA-C IN DENOVO ACUTE MYELOID-LEUKEMIA WITH TRILINEAGE MYELODYSPLASIA
    KAWANO, F
    NISHIMURA, Y
    TSUKAMOTO, A
    SATOH, M
    SANADA, I
    SHIDO, T
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 1992, 55 (01) : 101 - 102
  • [48] LOW-DOSE ARA-C IN THE TREATMENT OF ACUTE-LEUKEMIA CYTO-TOXICITY OR DIFFERENTIATION INDUCTION
    HOELZER, D
    GANSER, A
    ANGER, B
    SEIFRIED, E
    HEIMPEL, H
    BLUT, 1984, 48 (04): : 233 - 238
  • [49] Amifostine as a single agent or in a combination regimen with low-dose ARA-C in the treatment of myelodysplastic syndromes.
    Grossi, A
    Fabbri, A
    Santini, V
    Longo, G
    Leoni, F
    Vannucchi, AM
    Pagliai, G
    Ferrini, PR
    BLOOD, 1998, 92 (10) : 632A - 632A
  • [50] Homoharringtonine and low-dose Ara-C is a highly effective combination for the treatment of CML in chronic phase.
    Ernst, TJ
    Vance, E
    Alyea, E
    Soiffer, R
    Quartulli, M
    Ritz, J
    BLOOD, 1997, 90 (10) : 2305 - 2305